Floatz logo

Therapeutic Asset Ratings

5,099 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bicalutamide
Prostate Carcinoma
Baptist Health South FloridaP3B (60)
Bleomycin
Malignant Germ Cell Tumor Of Ovary
Children's Oncology GroupP3B (60)
Bleomycin
Ovarian Embryonal Carcinoma
Children's Oncology GroupP3B (60)
Bleomycin
Ovarian Yolk Sac Tumor
Children's Oncology GroupP3B (60)
Bleomycin
Testicular Embryonal Carcinoma
Children's Oncology GroupP3B (60)
Bl-M07D1
HER2 Positive Breast Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3B (60)
Bortezomib
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3B (60)
Bortezomib
Mantle Cell Lymphoma
Ruijin HospitalP3B (60)
Bortezomib
Neoplasm
Hellenic Society of HematologyP3B (60)
Brigatinib
Cancer
University Health Network, TorontoP3B (60)
Brivaracetam
Childhood Absence Epilepsy
UCB Biopharma SRLP3B (60)
Brivaracetam
Juvenile Absence Epilepsy
UCB Biopharma SRLP3B (60)
Brivaracetam Film-Coated
Childhood Absence Epilepsy
UCB Biopharma SRLP3B (60)
Brivaracetam Film-Coated
Juvenile Absence Epilepsy
UCB Biopharma SRLP3B (60)
Cabazitaxel
Castration-Resistant Prostate Carcinoma
Jina Pharmaceuticals Inc.P3B (60)
Cabozantinib
Cancer
ExelixisP3B (60)
Cabozantinib
Metastatic Malignant Neoplasm
Rana McKay, MDP3B (60)
Cagrilintide
Type 2 Diabetes Mellitus
Novo Nordisk A/SP3B (60)
Calcined Magnesia
Vascular Disorder
Coordinación de Investigación en Salud, MexicoP3B (60)
Camustine
Breast Cancer
General Oncology, Inc.P3B (60)
Camustine
T-Cell Non-Hodgkin Lymphoma
Sichuan UniversityP3B (60)
Camustine
Mantle Cell Lymphoma
Ruijin HospitalP3B (60)
Capecitabine
Colon Carcinoma
Sun Yat-sen UniversityP3B (60)
Capecitabine
Hepatocellular Carcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P3B (60)
Capecitabine
Liver Cancer
Niek WijnenP3B (60)
Showing 2276 to 2300 of 5,099 assets
PreviousPage 92 of 204Next